期刊文献+

他汀类药物改善脓毒症患者内皮细胞功能的机制研究进展 被引量:5

暂未订购
导出
摘要 脓毒症是感染引起的失控的全身炎症反应综合征.脓毒症时全身炎症平衡紊乱可导致进行性的内皮细胞(EC)功能障碍,白细胞和血小板被激活,凝血纤溶破坏,最终导致多器官功能衰竭[1].EC功能障碍是脓毒症发展恶化的中心环节.脓毒症的发病率逐年上升,有资料显示[2],脓毒症的病死率为25%~80%.近年来国外有研究证明他汀类药物治疗脓毒症能够降低其发病率及病死率,其主要机制之一可能与保护内皮细胞功能有关.现对他汀类药物保护脓毒症内皮细胞(EC)功能的机制作一综述.
出处 《临床合理用药杂志》 2012年第18期164-166,共3页 Chinese Journal of Clinical Rational Drug Use
  • 相关文献

参考文献38

  • 1Hoesel LM,Gao H,Ward PA. New insights into cellular mechanisms during sepsis[J].Immunologic Research,2006,(02):133-141.doi:10.1385/IR:34:2:133.
  • 2Fidan H,Sahin O,Yavuz Y. Caffeic acid phenethyl ester reduces mortality and sepsis-induced lung injury in rats[J].Critical Care Medicine,2007,(12):2822.doi:10.1097/01.CCM.0000295588.86982.7D.
  • 3Mc-Gown CC,Brookes ZLS. Beneficial effects of statins on the microcirculation during sepsis:the role of nitric oxide[J].British Journal of Anaesthesia,2007,(2):163-175.doi:10.1093/bja/ael358.
  • 4Waldow T,Witt W,Weber E. Nitric oxide donorinduced persistent inhibition of cell adhesion protein expression and NFkappaB activation in endothelial cells[J].Nitric Oxide:Biology and Chemistry,2006.103-113.
  • 5冼海涛,姚华国,张媛莉.他汀类药物对脓毒症一氧化氮合酶的影响[J].中国热带医学,2008,8(3):487-489. 被引量:6
  • 6Yildiz A,Cakar MA,Baskurt M. The effects of atorvastatin therapy on endothelial function in patients with coronary artery disease[J].Cardio-vasc Ultrasound,2007.51.doi:10.1186/1476-7120-5-51.
  • 7Fox A,Smythe J,Fisher N. Mobilization of endothelial progenitor cells into the circulation in burned patients[J].British Journal of Surgery,2008,(02):244-251.
  • 8Kusuyama T,Omura T,Nishiya D. The effects of HMG-CoA reductase inhibitor on vascular progenitor cells[J].Journal of Pharmaceutical Sciences,2006.344-349.
  • 9Schamig K,Busch G,Steppich B. Interleukin-8 is associated with circulating CD133+ progenitor cells in acute myocardial infarction[J].European Heart Journal,2006.1032-1037.
  • 10侯淑红,王挹青.内皮祖细胞与动脉粥样硬化及他汀类药物的干预[J].中国组织工程研究与临床康复,2008,12(20):3947-3950. 被引量:4

二级参考文献94

共引文献25

同被引文献61

  • 1孙淑荣,刘业清,王荣辉.参附注射液对严重脓毒血症和脓毒性休克早期复苏的干预研究[J].中国中医急症,2007,16(10):1214-1215. 被引量:13
  • 2Lomas-Neira J, Perl M, Venet F, et al. The role and source of tumor necro- sis factor-α in hemorrhage-induced priming for septic lung injury [J]. Shock,2012 ,37 (6) :611-20.
  • 3Akinosoglou K,Alexopoulos D.Use of antiplatelet agents in sepsis:aglimpse into the future[J].Thromb Res,2014,133(2):131-138.
  • 4Iwaszko-Simonik A,Niedzwiedz A,Graczyk S,et al.Expression of surface platelet receptors(CD62Pand CD41/61)in horses with recurrent airway obstruction(RAO)[J].Vet Immunol Immunopathol,2015,164(1-2):87-92.
  • 5Semple J W,Italiano J E Jr,Freedman J.Platelets and the immune continuum[J].Nat Rev Immunol,2011,11(4):264-274.
  • 6Katz J N,Kolappa K P,Becker R C.Beyond thrombosis:the versatile platelet in critical illness[J].Chest,2011,139(3):658-668.
  • 7Blit P H,McClung W G,Brash J L,et al.Platelet inhibition and endothelial cell adhesion on elastin-like polypeptide surface modified materials[J].Biomaterials,2011,32(25):5790-5800.
  • 8Johansson M W,Han S T,Gunderson K A,et al.Platelet activation,P-selectin,and eosinophil beta1-integrin activation in asthma[J].Am J Respir Crit Care Med,2012,185(5):498-507.
  • 9Semeraro N,Ammollo C T,Semeraro F,et al.Coagulopathy of Acute Sepsis[J].Semin Thromb Hemost,2015,41(6):650-658.
  • 10Valerio-Rojas J C,Jaffer I J,Kor D J,et al.Outcomes of severe sepsis and septic shock patients on chronic antiplatelet treatment:a historical cohort study[J].Crit Care Res Pract,2013,2013:782573.

引证文献5

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部